Venetoclax‐based non‐intensive combinations for relapsed/refractory acute myeloid leukaemia—Real‐world data from a UK ‐wide programme
Year: 2025
Type: article
Study design: Observational Study
Abstract: Data that support the findings of this study are available upon reasonable request from the corresponding author. Data S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Source: British Journal of Haematology
DOI: 10.1111/bjh.20149
Authors: Henry Wood, Jenny O'Nions, Wei Yee Chan, Albert Borg, Scott Veitch, Patrick Elder, Manish Jain, James Aries, Steven Leak, Emily Mitchell, Jiri Pavlu, Jad Othman, Richard Dillon, Priyanka Mehta, Vidhya Murthy, Steven Knapper, Victoria Potter, Mhairi Copland, Charles Craddock, Pramila Krishnamurthy
Institutions: King's College Hospital, University College London, Hammersmith Hospital, Imperial College London, St Thomas' Hospital, Leeds Teaching Hospitals NHS Trust, Barts Health NHS Trust, University of Glasgow, Cambridge University Hospitals NHS Foundation Trust, The University of Sydney, King's College London, University Hospitals Bristol and Weston NHS Foundation Trust, Cardiff University, University of Warwick
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4410570855